Inclusion complexation of weakly acidic NSAID with β-cyclodextrin: Selection of arginine, an amino acid, as a novel ternary component

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 69, Issue 3-4, 2011, Pages 453-460

  Bramhane, D M ^a   Saindane, N S ^a   Vavia, P R ^a  

^a INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Cyclodextrin; Lornoxicam; Solid complex

Indexed keywords

EID: 79955951977     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-010-9783-7     Document Type: Conference Paper

References (23)

1. Merck Index, 13th edn, p. 1000. Merck and Co. Inc., Whitehouse Station, NJ, USA (2001)
2. Gilman, A. G., Limbird, L. E., Hardman, J. G.: The Pharmacological Basis of Therapeutics, 10th edn, p. 731. Goodman and Gilman's, McGraw-Hill, New York, USA (2001)
3. ® rapid: a novel effective tool for pain treatment. Eur. Surg. 38(53), 342-352 (2006) (Pubitemid 44787125)
4. Horter, D., Dressman, J. B.: Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv. Drug Deliv. Rev. 46, 75-87 (2001)
5. Loftsson, T., Brewster, M.: Pharmaceutical application of cyclodextrins. I. Drug solubilization and stabilization. J. Pharm. Sci. 85, 1017-1025 (1996) (Pubitemid 26338912)
6. Uekama, K., Otagiri, M.: Cyclodextrins in drug carrier systems. Crit. Rev. Ther. Drug Carrier Syst. 3, 1-40 (1987) (Pubitemid 17231927)
7. Rajewski, R. A., Stella, V. J.: Pharmaceutical application of cyclodextrins. II. In vivo drug delivery. J. Pharm. Sci. 85, 1142-1169 (1996) (Pubitemid 26372882)
8. Vavia, P. R., Adhage, N. A.: Inclusion complexation of nimesulide with β-cyclodextrins. Drug Dev. Ind. Pharm. 25(4), 543-545 (1999)
9. Chavanpatil, M., Dawre, F. D., Shakleya, D. S., Vavia, P. R.: Enhancement of oral bioavailability of rofecoxib using β-cyclodextrin. J. Incl. Phenom. Macrocycl. Chem. 44, 1-4, 44(2002)
10. Bettinetti, G. P., Gazzaniga, A., Mura, P., Giordano, F., Setti, M.: Thermal behavior and dissolution properties of naproxen in combinations with chemically modified β-cyclodextrins. Drug Dev. Ind. Pharm. 18, 39-53 (1992)
11. Bernard, F., Florence, M., Hubert, L.: Inclusion complexes containing piroxicam, cyclodextrin and arginine. US patent application 2007027037A1
12. Moore, J. W., Flanner, H.: Mathematical comparison of dissolution profiles. Pharm. Tech. 20, 64-74 (1996) (Pubitemid 126450495)
13. Paola, M., Francesca, M., Marzia, C.: Ternary systems of naproxen with hydroxypropyl-B-cyclodextrin and aminoacids. Int. J. Pharm. 260, 293-302 (2003)
14. Higuchi, T., Connors, K. A.: Phase-solubility techniques. Adv. Anal. Chem. Instrum. 4, 117-212 (1965)
15. Fu, G, Wen, M., Guo, X.: HPLC determination of content and related substances of lornoxicam for injection. Chin. J. Pharm. Anal. 24(4), 434-435 (2004)
16. Huai, Y. W., Juan, H., Xia, G. F.: Spectroscopic study of orange G-B cyclodextrin complex and its analytical application. Spectrochim. Acta A. 66, 578-585 (2007)
17. Mauricio, F., Matías, I. S., Estela, G.: Encapsulation of methyl and ethyl salicylates by B-cyclodextrin HPLC, UV-vis and molecular modeling studies. J. Pharm. Biomed. Anal. 48, 969-973 (2008)
18. Poul, B., Gjørløv, H., Hermann, R., Shigeru, I.: Quick release pharmaceutical compositions of drug substances. US patent 6, 713, 0891 B1
19. Kim, K. H., Frank, M. J., Henderson, N. L.: Applications of differential scanning calorimetry to the study of solid drug dispersions. J. Pharm. Sci. 74, 283-289 (1985) (Pubitemid 15105917)
20. Amareshwar, K., Rai, D. K.: Spectroscopic studies of some antidiabetic drugs. Spectrochim. Acta A. 59, 1673-1680 (2003)
21. Pcnkler, J. L.: Pharmaceutical compositions containing lornoxicam and cyclodextrin. Pat. WO 96/41646 (1996)
22. 1H-NMR and molecular modeling studies. J. Pharm. Biomed. Anal. 41, 857-865 (2006)
23. Upadhyay, S. K., Ali, S. M.: Solution structure of loperamide and â-cyclodextrin inclusion complexes using NMR spectroscopy. J. Chem. Sci. 121(4), 521-527 (2009)